Physical activity as a moderator for obstructive sleep apnoea and cardiometabolic risk in the EPISONO study

Obstructive sleep apnoea (OSA) is positively associated with cardiometabolic diseases; however, high levels of physical activity could decrease the incidence of OSA and associated comorbidities.In this study we aimed to examine the incidence of OSA in relation to physical activity, and its role as a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2018-10, Vol.52 (4), p.1701972
Hauptverfasser: Mônico-Neto, Marcos, Moreira Antunes, Hanna Karen, Dos Santos, Ronaldo Vagner Thomatieli, D'Almeida, Vânia, Alves Lino de Souza, Altay, Azeredo Bittencourt, Lia Rita, Tufik, Sergio
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Obstructive sleep apnoea (OSA) is positively associated with cardiometabolic diseases; however, high levels of physical activity could decrease the incidence of OSA and associated comorbidities.In this study we aimed to examine the incidence of OSA in relation to physical activity, and its role as a protective factor in individuals with OSA on the incidence of cardiometabolic diseases, in an 8-9-year follow-up study. We analysed data of 658 volunteers from the São Paulo Epidemiologic Sleep Study (EPISONO), a cohort study of individuals aged 20-80 years, collected through polysomnography, the International Physical Activity Questionnaire and an assessment of cardiometabolic profile.Active subjects had a lower risk of developing OSA compared with nonactive subjects (relative risk 0.877, 95% CI 0.296-0.855) and there was a reduced risk of developing type 2 diabetes mellitus in active/apnoeic subjects (relative risk 0.493, 95% CI 0.252-0.961) compared with nonactive subjects. Metabolic equivalent was negatively associated to cardiometabolic markers, such as C-reactive protein (exp( )=0.720; p=0.001), interleukin-6 (exp( )=0.991; p=0.03), insulin (exp( )=0.982; p=0.03), triglycerides (exp( )=0.997; p
ISSN:0903-1936
1399-3003
DOI:10.1183/13993003.01972-2017